NDAs Supported By Foreign Data To Be Reviewed By HHS Inspector General
Executive Summary
HHS' Office of Inspector General will examine how FDA handles the growing number of clinical trials being conducted overseas
You may also be interested in...
Drug Manufacturer Supply Options Could Be Constricted By Legislation
A more compact supply chain for pharmaceutical companies could result from congressional efforts to legislate greater emphasis on drug quality - both by FDA and by industry
Clinical Trial Outsourcing: Germany Is #2; India’s Investigator Ranks Jump 30%
Germany ranks just behind the United States as the go-to place for FDA-regulated clinical trials